US expand use of Janssen's Darzalex
The Pharma Data
AUGUST 20, 2020
US regulators have approved Janssen’s Darzalex (daratumumab) in combination with carfilzomib and dexamethasone (DKd) for the treatment of adults with relapsed/refractory multiple myeloma who have received one to three previous lines of therapy. . Source link.
Let's personalize your content